SELLAS Life Sciences Group Inc. Common Stock vs Welltower Inc. Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.33 (market cap $2.27B), while Welltower Inc. Common Stock trades at $223.24 (market cap $159.33B). The key difference: Welltower Inc. Common Stock is far larger — about 70.2× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Welltower Inc. Common Stock pays a 1.54% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | WELL | |
|---|---|---|
Market Cap | $2.27B | $159.33B |
Volume | 4,179,659 | 2,484,986 |
Sector | Health | Real Estate |
52-Week High | $15.46 | $252.07 |
52-Week Low | $1.39 | $165.94 |
Enterprise Value | $2.14B | $177.09B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 1.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →Welltower is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, outpatient medical facilities, and other health-related real estate.
Read more on WELL →